MEDULLARY CARCINOMA
Clinical trials for MEDULLARY CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new MEDULLARY CARCINOMA trials appear
Sign up with your email to follow new studies for MEDULLARY CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could Once-Daily radiation replace Twice-Daily for breast cancer recurrence?
Disease control Recruiting nowThis study is for women whose breast cancer has come back after initial breast-conserving surgery and whole breast radiation. The standard treatment after repeat surgery is radiation twice a day for 30 sessions. This trial tests whether giving radiation once a day for 15 sessions…
Matched conditions: MEDULLARY CARCINOMA
Phase: PHASE2 • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Promising new therapy targets rare, aggressive cancers
Disease control Recruiting nowThis study tests whether the drug ubamatamab, alone or with cemiplimab, can help control rare cancers like renal medullary carcinoma and epithelioid sarcoma. About 40 adults with advanced or metastatic disease will receive the treatment to check safety and effectiveness. The goal…
Matched conditions: MEDULLARY CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC